DocWire News Editors

DocwireNews

Patients with multiple myeloma (MM) often face relapsed/refractory disease despite initial responses to firstline treatment. B-cell maturation antigen (BCMA) has emerged as a promising target for the treatment of MM.Belantamab mafodotin is an experimental antibody-drug conjugate that targets BCMA that initially showed activity as a single agent in relapsed/refractory MM. In the multicenter, phase II, ongoing DREAMM-2 study, 31% of patients (n=30) who received belantamab mafodotin 2.5 mg/kg and 34% (n=34) who received belantamab mafodotin 3.4 mg/kg achieved an overall response, including three complete responses.Paul G. Richardson, MD, the clinical program leader and director of clinical research at the Jerome Lipper Multiple My&shy;eloma Center at the Dana-Farber Cancer Institute and RJ Corman Professor of Med&shy;icine at Harvard Medical School, discussed the outcomes of the DREAMM-2 study and how he sees belantamab mafodotin impacting the MM treatment landscape.<a href="https://www.docwirenews.com/hematology-oncology/novel-anti-bcma-therapy-induces-response-in-heavily-pretreated-multiple-myeloma/attachment/novel_anti-bcma_therapy/">Read More</a>

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Novel Anti-BCMA Therapy Induces Response in Heavily Pretreated Multiple Myeloma

Oncology

Patients with multiple myeloma (MM) often face relapsed/refractory disease despite initial responses to firstline treatment. B-cell maturation antigen (BCMA) has emerged as a ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe